Cytocom Inc. — Form D
Cytocom Inc. of Fort Collins, CO, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-21. The offering totals $15.0M, of which $2.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-07-21
- Form: D
- Accession: 0001493152-20-013638
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $2.3M
- Remaining: $12.7M
- Minimum investment: $25K
- Investors: 10
- Date of first sale: 2020-05-01
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-371423
Issuer
- Name: Cytocom Inc.
- CIK: 0001815773
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2537 Research Blvd, Suite 201, Fort Collins, CO, 80526
- Phone: 888-629-4155
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Noreen McGurrin Griffin | Director | Winter Park, FL |
| Michael Handley | Director | Fremont, CA |
| Noreen McGurrin Griffin | Executive Officer | Winter Park, FL |
| Michael Handley | Executive Officer | Fremont, CA |
| Cozette McGurrin McAvoy | Executive Officer | Winter Park, FL |
| Peter Aronstam | Executive Officer | Fort Collins, CO |
| Taunia Markvicka | Director | Fort Collins, CO |
| Taunia Markvicka | Executive Officer | Fort Collins, CO |
| Clifford K Selsky | Executive Officer | Fort Collins, CO |
| Noreen K Griffin | Director | Fort Collins, CO |
| Noreen K Griffin | Executive Officer | Fort Collins, CO |
| Cozette K McAvoy | Executive Officer | Fort Collins, CO |
| Michael K Handley | Director | Fort Collins, CO |
| Michael K Handley | Executive Officer | Fort Collins, CO |
Other filings by this issuer (1)
More